創傷ケア生物製剤の世界市場2020-2026:生物学的皮膚代替物、酵素ベース製剤、成長因子

QYResearchが発行した調査報告書(QYR20AP02681)
◆英語タイトル:Global Wound Care Biologics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02681
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、創傷ケア生物製剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、創傷ケア生物製剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(生物学的皮膚代替物、酵素ベース製剤、成長因子)、用途別市場規模(急性創傷、慢性創傷、外科創傷)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・創傷ケア生物製剤の種類別市場2015-2026:生物学的皮膚代替物、酵素ベース製剤、成長因子
・創傷ケア生物製剤の用途別市場2015-2026:急性創傷、慢性創傷、外科創傷
・創傷ケア生物製剤の北米市場分析
・創傷ケア生物製剤のアジア市場分析
・創傷ケア生物製剤の中南米市場分析
・創傷ケア生物製剤の中東・アフリカ市場分析
・関連企業情報:Smith & Nephew、Organogenesis、MiMedx、Integra、Osiris、Derma Sciences, Inc、Soluble Systems、Amnio Technology, LLC、Medline、Skye® Biologics、Alphatec Spine,Inc.、Pinnacle Transplant Technologies
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.

With the development of medical technology level, more and more companies participate in this industry.
In 2019, the global Wound Care Biologics market size was US$ 3187 million and is forecast to US$ 6542.8 million in 2026, growing at a CAGR of 10.7% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Wound Care Biologics.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Wound Care Biologics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Wound Care Biologics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Wound Care Biologics market. Readers of the report can become informed about current and future trends of the global Wound Care Biologics market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Wound Care Biologics markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Wound Care Biologics market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Wound Care Biologics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Wound Care Biologics market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Wound Care Biologics market is segmented into
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors

Market Segment by Application, the Wound Care Biologics market is segmented into
Acute Wounds
Chronic Wounds
Surgical Wounds

This report includes the following manufacturers; we can also add the other companies as you want.
Smith & Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies

The study objectives are:
To analyze and research the global Wound Care Biologics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Wound Care Biologics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Wound Care Biologics are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Wound Care Biologics Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Wound Care Biologics Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Biologic Skin Substitutes
1.3.3 Enzyme Based Formulations
1.3.4 Growth Factors
1.4 Market Segment by Application
1.4.1 Global Wound Care Biologics Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Acute Wounds
1.4.3 Chronic Wounds
1.4.4 Surgical Wounds
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Wound Care Biologics Revenue (2015-2026)
2.1.1 Global Wound Care Biologics Revenue (2015-2026)
2.1.2 Global Wound Care Biologics Sales (2015-2026)
2.2 Wound Care Biologics Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Wound Care Biologics Sales by Regions (2015-2020)
2.2.2 Global Wound Care Biologics Revenue by Regions (2015-2020)
2.3 Global Top Wound Care Biologics Regions (Countries) Ranking by Market Size
2.4 Wound Care Biologics Industry Trends
2.4.1 Wound Care Biologics Market Top Trends
2.4.2 Market Drivers
2.4.3 Wound Care Biologics Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Wound Care Biologics Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Wound Care Biologics Manufacturers by Sales (2015-2020)
3.1.1 Global Wound Care Biologics Sales by Manufacturers (2015-2020)
3.1.2 Global Wound Care Biologics Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Wound Care Biologics Sales in 2019
3.2 Global Top Manufacturers Wound Care Biologics by Revenue
3.2.1 Global Wound Care Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Global Wound Care Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wound Care Biologics as of 2019)
3.4 Global Wound Care Biologics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Wound Care Biologics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Wound Care Biologics Market
3.7 Key Manufacturers Wound Care Biologics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Wound Care Biologics Historic Market Review by Type (2015-2020)
4.1.2 Global Wound Care Biologics Sales Market Share by Type (2015-2020)
4.1.3 Global Wound Care Biologics Revenue Market Share by Type (2015-2020)
4.1.4 Wound Care Biologics Price by Type (2015-2020)
4.1 Global Wound Care Biologics Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Wound Care Biologics Sales Forecast by Type (2021-2026)
4.2.3 Global Wound Care Biologics Revenue Forecast by Type (2021-2026)
4.2.4 Wound Care Biologics Price Forecast by Type (2021-2026)

5 Global Wound Care Biologics Market Size by Application
5.1 Global Wound Care Biologics Historic Market Review by Application (2015-2020)
5.1.2 Global Wound Care Biologics Sales Market Share by Application (2015-2020)
5.1.3 Global Wound Care Biologics Revenue Market Share by Application (2015-2020)
5.1.4 Wound Care Biologics Price by Application (2015-2020)
5.2 Global Wound Care Biologics Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Wound Care Biologics Sales Forecast by Application (2021-2026)
5.2.3 Global Wound Care Biologics Revenue Forecast by Application (2021-2026)
5.2.4 Wound Care Biologics Price Forecast by Application (2021-2026)

6 North America
6.1 North America Wound Care Biologics Breakdown Data by Company
6.2 North America Wound Care Biologics Breakdown Data by Type
6.3 North America Wound Care Biologics Breakdown Data by Application
6.4 North America Wound Care Biologics Breakdown Data by Countries
6.4.1 North America Wound Care Biologics Sales by Countries
6.4.2 North America Wound Care Biologics Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Wound Care Biologics Breakdown Data by Company
7.2 Europe Wound Care Biologics Breakdown Data by Type
7.3 Europe Wound Care Biologics Breakdown Data by Application
7.4 Europe Wound Care Biologics Breakdown Data by Countries
7.4.1 Europe Wound Care Biologics Sales by Countries
7.4.2 Europe Wound Care Biologics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Wound Care Biologics Breakdown Data by Company
8.2 Asia Pacific Wound Care Biologics Breakdown Data by Type
8.3 Asia Pacific Wound Care Biologics Breakdown Data by Application
8.4 Asia Pacific Wound Care Biologics Breakdown Data by Regions
8.4.1 Asia Pacific Wound Care Biologics Sales by Regions
8.4.2 Asia Pacific Wound Care Biologics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Wound Care Biologics Breakdown Data by Company
9.2 Latin America Wound Care Biologics Breakdown Data by Type
9.3 Latin America Wound Care Biologics Breakdown Data by Application
9.4 Latin America Wound Care Biologics Breakdown Data by Countries
9.4.1 Latin America Wound Care Biologics Sales by Countries
9.4.2 Latin America Wound Care Biologics Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Wound Care Biologics Breakdown Data by Type
10.2 Middle East and Africa Wound Care Biologics Breakdown Data by Application
10.3 Middle East and Africa Wound Care Biologics Breakdown Data by Countries
10.3.1 Middle East and Africa Wound Care Biologics Sales by Countries
10.3.2 Middle East and Africa Wound Care Biologics Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Smith & Nephew
11.1.1 Smith & Nephew Corporation Information
11.1.2 Smith & Nephew Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Smith & Nephew Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Smith & Nephew Wound Care Biologics Products and Services
11.1.5 Smith & Nephew SWOT Analysis
11.1.6 Smith & Nephew Recent Developments
11.2 Organogenesis
11.2.1 Organogenesis Corporation Information
11.2.2 Organogenesis Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Organogenesis Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Organogenesis Wound Care Biologics Products and Services
11.2.5 Organogenesis SWOT Analysis
11.2.6 Organogenesis Recent Developments
11.3 MiMedx
11.3.1 MiMedx Corporation Information
11.3.2 MiMedx Business Overview and Total Revenue (2019 VS 2018)
11.3.3 MiMedx Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 MiMedx Wound Care Biologics Products and Services
11.3.5 MiMedx SWOT Analysis
11.3.6 MiMedx Recent Developments
11.4 Integra
11.4.1 Integra Corporation Information
11.4.2 Integra Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Integra Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Integra Wound Care Biologics Products and Services
11.4.5 Integra SWOT Analysis
11.4.6 Integra Recent Developments
11.5 Osiris
11.5.1 Osiris Corporation Information
11.5.2 Osiris Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Osiris Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Osiris Wound Care Biologics Products and Services
11.5.5 Osiris SWOT Analysis
11.5.6 Osiris Recent Developments
11.6 Derma Sciences, Inc
11.6.1 Derma Sciences, Inc Corporation Information
11.6.2 Derma Sciences, Inc Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Derma Sciences, Inc Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Derma Sciences, Inc Wound Care Biologics Products and Services
11.6.5 Derma Sciences, Inc SWOT Analysis
11.6.6 Derma Sciences, Inc Recent Developments
11.7 Soluble Systems
11.7.1 Soluble Systems Corporation Information
11.7.2 Soluble Systems Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Soluble Systems Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Soluble Systems Wound Care Biologics Products and Services
11.7.5 Soluble Systems SWOT Analysis
11.7.6 Soluble Systems Recent Developments
11.8 Amnio Technology, LLC
11.8.1 Amnio Technology, LLC Corporation Information
11.8.2 Amnio Technology, LLC Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Amnio Technology, LLC Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Amnio Technology, LLC Wound Care Biologics Products and Services
11.8.5 Amnio Technology, LLC SWOT Analysis
11.8.6 Amnio Technology, LLC Recent Developments
11.9 Medline
11.9.1 Medline Corporation Information
11.9.2 Medline Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Medline Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Medline Wound Care Biologics Products and Services
11.9.5 Medline SWOT Analysis
11.9.6 Medline Recent Developments
11.10 Skye® Biologics
11.10.1 Skye® Biologics Corporation Information
11.10.2 Skye® Biologics Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Skye® Biologics Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Skye® Biologics Wound Care Biologics Products and Services
11.10.5 Skye® Biologics SWOT Analysis
11.10.6 Skye® Biologics Recent Developments
11.11 Alphatec Spine,Inc.
11.11.1 Alphatec Spine,Inc. Corporation Information
11.11.2 Alphatec Spine,Inc. Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Alphatec Spine,Inc. Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Alphatec Spine,Inc. Wound Care Biologics Products and Services
11.11.5 Alphatec Spine,Inc. SWOT Analysis
11.11.6 Alphatec Spine,Inc. Recent Developments
11.12 Pinnacle Transplant Technologies
11.12.1 Pinnacle Transplant Technologies Corporation Information
11.12.2 Pinnacle Transplant Technologies Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Pinnacle Transplant Technologies Wound Care Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Pinnacle Transplant Technologies Wound Care Biologics Products and Services
11.12.5 Pinnacle Transplant Technologies SWOT Analysis
11.12.6 Pinnacle Transplant Technologies Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Wound Care Biologics Sales Channels
12.2.2 Wound Care Biologics Distributors
12.3 Wound Care Biologics Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Wound Care Biologics Sales Forecast (2021-2026)
13.1.1 Global Wound Care Biologics Sales Forecast by Regions (2021-2026)
13.1.2 Global Wound Care Biologics Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Wound Care Biologics Sales Forecast (2021-2026)
13.2.2 North America Wound Care Biologics Revenue Forecast (2021-2026)
13.2.3 North America Wound Care Biologics Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Wound Care Biologics Sales Forecast (2021-2026)
13.3.2 Europe Wound Care Biologics Revenue Forecast (2021-2026)
13.3.3 Europe Wound Care Biologics Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Wound Care Biologics Sales Forecast (2021-2026)
13.4.2 Asia Pacific Wound Care Biologics Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Wound Care Biologics Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Wound Care Biologics Sales Forecast (2021-2026)
13.5.2 Latin America Wound Care Biologics Revenue Forecast (2021-2026)
13.5.3 Latin America Wound Care Biologics Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Wound Care Biologics Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Wound Care Biologics Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Wound Care Biologics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Smith & Nephew、Organogenesis、MiMedx、Integra、Osiris、Derma Sciences, Inc、Soluble Systems、Amnio Technology, LLC、Medline、Skye® Biologics、Alphatec Spine,Inc.、Pinnacle Transplant Technologies

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 創傷ケア生物製剤の世界市場2020-2026:生物学的皮膚代替物、酵素ベース製剤、成長因子(Global Wound Care Biologics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。